ETF Action: Research

ETF Playbooks

(*Available to Subscribers Only)

Weekly reviews of popular ETF market segments, including visualizations of major market moves, performance highlights, technical trends and more.


Markets covered include:



DOWNLOAD A SAMPLE

ETF Playbooks Archives

 Global Thematic Playbook

9.22.2021

An overview of the Global Thematic ETF landscape - Performance, Flows, Valuations, Earnings, & Technicals.

  • Notable net inflows for Global Thematic ETFs from the past week include the ARK Innovation ETF (ARKK), which gathered $252 million, and the ProShares Online Retail ETF (ONLN), which added $93 million
  • Fintech ETFs are down 7.51% thus far in September as Blockchain ETFs dragged performance 
  • Health Innovation ETFs led other thematic segments over the past month, bolstered by solid gains from Biotech and Cancer Immunotherapy ETFs
  • The Loncar Cancer Immunotherapy ETF (CNCR) has been the top performer over the last month, climbing nearly 12%, while the ALPS Medical Breakthroughs ETF (SBIO) is up almost 10% and the Virtus LifeSci Biotech Clinical Trials ETF (BBC) returned +8.67%
  • Despite continued COVID-19 related travel restrictions around the globe, the ETFMG Travel Tech ETF (AWAY) is up an impressive 10.64% in the past month

 

 U.S. Factor Playbook

9.21.2021

An overview of the U.S. Factor ETF landscape - Performance, Flows, Valuations, Earnings, & Technicals.

  • All U.S. Factor strategies are down more than 3% month-to-date as markets trudge through September
  • Dividend ETFs pulled in another $1.1 billion in net inflows over the past week bringing its 3-month net inflows to over $6.5 billion
  • The Innovator IBD 50 ETF (FFTY), a Growth/ Momentum ETF, once again outpaced other U.S. Factor ETFs gaining 8.65% over the past month. FFTY is up 36.50% in the last year

 

 

 U.S. Sector & Industry Playbook

9.20.2021

An overview of the U.S. Sector ETF landscape - Performance, Flows, Valuations, Earnings, & Technicals.

  • Technology ETFs led net inflows over the past week pulling in over $2 billion. Energy ETFs, which have outperformed other sector ETFs year-to-date on average, also gathered $758 million in net inflows last week
  • The SPDR S&P Biotech ETF (XBI) saw sizeable net outflows ($339 million) for the second consecutive week. XBI has seen nearly $1 billion in net outflows over the past 3 months
  • The Invesco DWA Energy Momentum ETF (PXI) was the top performer in the past month climbing 17.75%. PXI is up over 93% in the past one year

 

 

 Global Thematic Playbook

9.15.2021

An overview of the Global Thematic ETF landscape - Performance, Flows, Valuations, Earnings, & Technicals.

  • Sustainability ETFs have gathered nearly $13 billion in net inflows over the past year, making it the third largest thematic segment
  • The ARK suite of ETFs saw net outflows over the past past week, the ARK Innovation ETF (ARKK) saw $242 million, the ARK Next Generation Internet ETF (ARKW) saw $143 million, and the ARK Genomic Revolution ETF (ARKG) saw $104 million
  • Disruptive Tech ETFs and Health Innovation ETFs each gained over 2% in the past month and outperformed other thematic segments
  • Cannabis was the worst performing thematic group over the past month as 7 Cannabis ETFs posted double digit declines in the period. The worst performers were the AdvisorShares Pure US Cannabis ETF (MSOS) and the Global X Cannabis ETF (POTX) which dropped 16.22% and 15.16%, respectively

 

 U.S. Factor Playbook

9.14.2021

An overview of the U.S. Factor ETF landscape - Performance, Flows, Valuations, Earnings, & Technicals.

  • Despite declining 1.71% thus far in September, Value ETFs are up nearly 25% year-to-date and have, on average, outperformed other U.S. Factor Strategies in the period
  • Quality ETFs saw $626 million in net outflows over the past week as other U.S. Factor Strategies saw relatively muted net flows
  • The Innovator IBD 50 ETF (FFTY) was the top performer over the past month, returning 5.60% 
  • Low Volatility (SPLV) continues to trail SPY over the trailing 12-month period while Value (SPVU) and Dividend (SPYD) have notably outperformed

 U.S. Sector & Industry Playbook

9.13.2021

An overview of the U.S. Sector ETF landscape - Performance, Flows, Valuations, Earnings, & Technicals.

  • Financials ETFs, which gained over 4% in August, saw over $1.4 billion in net outflows over the past week while Real Estate ETFs gathered another $999 million in net inflows in the period
  • Despite being up over 4% over the past month, the SPDR S&P Biotech ETF (XBI) saw $442 million in next outflows last week. XBI is down 6.41% thus far in 2021
  • The iShares U.S. Medical Devices ETF (IHI) has gained 5.47% over the past month and has risen 21.25% year-to-date

 

 

 U.S. Size & Style Playbook

9.13.2021

An overview of the broad U.S. Size & Style ETF landscape - Performance, Flows, Valuations, Earnings, & Technicals.

  • Large Cap, Beta ETFs saw $1.73 billion in net inflows over the past week and have gathered over $51 billion in net inflows in the past 3 months
  • All Size & Style categories are down thus far in September after each seeing gains in August
  • The SPDR S&P 600 SmallCap Value ETF (SLYV) has been the worst performer in the past month, declining 3.24%. However, SLYV remains up nearly 22.5% year-to-date

 

 U.S. Factor Playbook

9.8.2021

An overview of the U.S. Factor ETF landscape - Performance, Flows, Valuations, Earnings, & Technicals.

  • Momentum/ Growth ETFs increased by nearly 2% over the past month while Low Volatility ETFs gained 1.1%
  • Dividend ETFs have seen nearly $7 billion in net inflows over the past 3 months and over $32 billion in net inflows over the past year
  • The Innovator IBD 50 ETF (FFTY) was the top performing U.S. Factor ETF over the past month, surging 9.51%

 

Sign Up